| Bacillus anthracis |
Anthrax lethal factor |
Potency |
10000.0 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
89125.1 |
nM |
None |
| Equus caballus |
Ferritin light chain |
Potency |
17782.8 |
nM |
None |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
50118.7 |
nM |
None |
| Escherichia coli K-12 |
Endonuclease 4 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
786-0 |
GI50 |
35.4 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
786-0 |
TGI |
64.6 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
Acid ceramidase |
IC50 |
500000.0 |
nM |
10.1021/acs.jmedchem.0c01561 |
| Homo sapiens |
Acid ceramidase |
Ki |
500000.0 |
nM |
10.1021/jm301879g |
| Homo sapiens |
Alpha-galactosidase A |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
11577.4 |
nM |
None |
| Homo sapiens |
Bloom syndrome protein |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
-1.73 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
1100.0 |
nM |
10.1021/jm051240y |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
1100.0 |
nM |
10.1021/jm900130m |
| Homo sapiens |
Cannabinoid CB2 receptor |
Ki |
10000.0 |
nM |
10.1021/jm051240y |
| Homo sapiens |
Cannabinoid CB2 receptor |
Ki |
10000.0 |
nM |
10.1021/jm900130m |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
-0.85 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
1069.1 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
-0.92 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
15848.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
31622.78 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
DNA polymerase beta |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
DNA polymerase eta |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
DNA polymerase kappa |
Potency |
21192.3 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.19 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.35 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.64 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.78 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.96 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.98 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
1.23 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
8436.8 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
EC50 |
930.0 |
nM |
10.1016/j.bmcl.2019.126855 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
EC50 |
2200.0 |
nM |
10.1016/j.bmc.2012.12.013 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
EC50 |
2200.0 |
nM |
10.1016/j.bmc.2016.10.030 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
EC50 |
2200.0 |
nM |
10.1016/j.bmcl.2012.12.011 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
EC50 |
2200.0 |
nM |
10.1016/j.bmcl.2017.03.092 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
EC50 |
3200.0 |
nM |
10.1016/j.bmc.2018.06.035 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
EC50 |
3200.0 |
nM |
10.1021/jm300484d |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
Emax |
100.0 |
% |
10.1016/j.bmcl.2012.12.011 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
Emax |
100.0 |
% |
10.1016/j.bmcl.2019.126855 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%max |
100.0 |
% |
10.1016/j.bmcl.2017.03.092 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
-2.08 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
HaCaT |
Activity |
nan |
None |
10.1016/j.bmc.2010.12.046 |
| Homo sapiens |
HaCaT |
LC50 |
14.4 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
HaCaT |
TGI |
53.5 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
Heat shock protein HSP 90-alpha |
AC50 |
7666.0 |
nM |
None |
| Homo sapiens |
HEK-293T |
Growth Rate |
-0.38 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.43 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.62 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.75 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.83 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
HERG |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-6.96 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.02 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
2238.7 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
LNCaP |
Control |
nan |
None |
10.1016/s0960-894x(00)00370-x |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
-1.79 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
MCF7 |
GI50 |
25.9 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
MCF7 |
TGI |
66.7 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
63095.7 |
nM |
None |
| Homo sapiens |
NAD-dependent protein deacetylase sirtuin-6 |
EC50 |
3100.0 |
nM |
10.1021/acs.jmedchem.1c00601 |
| Homo sapiens |
NAD-dependent protein deacetylase sirtuin-6 |
FC |
2.1 |
None |
10.1021/acs.jmedchem.1c00601 |
| Homo sapiens |
NAD-dependent protein deacetylase sirtuin-6 |
FC |
3.7 |
None |
10.1021/acs.jmedchem.1c00601 |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
9.1 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
NCI/ADR-RES |
TGI |
39.5 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
NCI-H460 |
GI50 |
36.5 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
NCI-H460 |
TGI |
81.0 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
32642.7 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
112.2 |
nM |
None |
| Homo sapiens |
Peregrin |
Delta TM |
-0.91 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
Activity |
nan |
None |
10.1016/j.bmcl.2015.05.045 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
Activity |
nan |
None |
10.1021/jm0601102 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
EC50 |
110.0 |
nM |
10.1021/jm0601102 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
EC50 |
120.0 |
nM |
10.1016/j.bmc.2016.08.067 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
EC50 |
152.0 |
nM |
10.1021/acs.jmedchem.5b00849 |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
EC50 |
152.0 |
nM |
10.1021/ml200091q |
| Homo sapiens |
Peroxisome proliferator-activated receptor alpha |
EC50 |
185.0 |
nM |
10.1021/ml200091q |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
EC50 |
1100.0 |
nM |
10.1016/j.bmc.2016.08.067 |
| Homo sapiens |
Prelamin-A/C |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Rap guanine nucleotide exchange factor 4 |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
-2.91 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-2.56 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Tumor susceptibility gene 101 protein |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
-1.47 |
C |
10.6019/CHEMBL5308504 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
2909.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
25929.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29855.4 |
nM |
None |
| Homo sapiens |
U-251 |
GI50 |
27.3 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
U-251 |
TGI |
51.3 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| Homo sapiens |
U2OS |
Growth Rate |
-0.18 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.54 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.62 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.68 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.74 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.76 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.79 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.81 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
U2OS |
Growth Rate |
0.87 |
None |
10.6019/CHEMBL5303304 |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Vanilloid receptor |
EC50 |
40.0 |
nM |
10.1021/jm300484d |
| Homo sapiens |
Vanilloid receptor |
EC50 |
890.0 |
nM |
10.1021/jm051240y |
| Homo sapiens |
Vanilloid receptor |
EC50 |
3650.0 |
nM |
10.1021/jm900130m |
| Homo sapiens |
Vanilloid receptor |
Emax |
50.1 |
% |
10.1021/jm051240y |
| Influenza A virus |
Nonstructural protein 1 |
Potency |
7079.5 |
nM |
None |
| Mus musculus |
Cannabinoid CB2 receptor |
Ki |
31000.0 |
nM |
10.1021/jm970257g |
| Mus musculus |
Glucose-dependent insulinotropic receptor |
EC50 |
2900.0 |
nM |
10.1021/acs.jmedchem.5b01198 |
| Mus musculus |
Mus musculus |
Activity |
-3.42 |
% |
10.1021/jm300484d |
| Mus musculus |
Mus musculus |
Activity |
-2.57 |
% |
10.1021/jm300484d |
| Mus musculus |
Mus musculus |
Activity |
-1.17 |
% |
10.1021/jm300484d |
| Mus musculus |
Mus musculus |
Activity |
-0.23 |
% |
10.1021/jm300484d |
| Mus musculus |
Mus musculus |
Activity |
-0.2 |
% |
10.1021/jm300484d |
| Mus musculus |
Mus musculus |
Activity |
-0.18 |
% |
10.1021/jm300484d |
| Mus musculus |
Mus musculus |
Activity |
-0.15 |
% |
10.1021/jm300484d |
| Mus musculus |
Mus musculus |
Activity |
1.43 |
% |
10.1021/jm300484d |
| Mus musculus |
RAW264.7 |
Activity |
117.0 |
% |
10.1016/j.bmc.2008.10.015 |
| Mycobacterium tuberculosis |
Acyl-CoA synthase |
AC50 |
100000.0 |
nM |
None |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
12.5 |
ug.mL-1 |
10.1016/j.bmcl.2010.06.149 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
25.0 |
ug.mL-1 |
10.1016/j.bmcl.2010.06.149 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1995.26 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3162.28 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3981.07 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
5011.87 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
6309.57 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7943.28 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2616.9 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2936.2 |
nM |
None |
| Plasmodium falciparum 3D7 |
HSP90 |
AC50 |
9250.0 |
nM |
None |
| Rattus norvegicus |
Anandamide amidohydrolase |
Rate of hydrolysis |
0.79 |
nM min-1 mg-1 |
10.1021/jm980461j |
| Rattus norvegicus |
Anandamide amidohydrolase |
Relative rate of hydrolysis |
61.1 |
% |
10.1021/jm980461j |
| Rattus norvegicus |
Cannabinoid CB1 receptor |
Ki |
10000.0 |
nM |
10.1021/jm980461j |
| Rattus norvegicus |
Cannabinoid CB1 receptor |
Ki |
20000.0 |
nM |
10.1021/jm970257g |
| Rattus norvegicus |
Cannabinoid CB1 receptor |
Ki |
44000.0 |
nM |
10.1021/jm970257g |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
23000.0 |
nM |
10.1021/jm051240y |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
0.0 |
% |
10.1016/s0960-894x(99)00148-1 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
100.0 |
% |
10.1016/s0960-894x(99)00148-1 |
| Rattus norvegicus |
RBL-2H3 |
IC50 |
20000.0 |
nM |
10.1021/jm051240y |
| Rattus norvegicus |
RBL-2H3 |
IC50 |
50000.0 |
nM |
10.1021/acs.jmedchem.9b00994 |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
25118.9 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
26679.5 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
28183.8 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
37685.8 |
nM |
None |
| Rattus norvegicus |
Transient receptor potential cation channel subfamily V member 2 |
IC50 |
1800.0 |
nM |
10.1021/acs.jmedchem.8b00734 |
| Rattus norvegicus |
Transient receptor potential cation channel subfamily V member 2 |
IC50 |
5400.0 |
nM |
10.1021/acs.jmedchem.8b00734 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
9.15 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
13.83 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.42 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
3.39 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
35.38 |
% |
10.21203/rs.3.rs-23951/v1 |
| Trypanosoma cruzi |
Cruzipain |
Potency |
19952.6 |
nM |
None |
| None |
ADMET |
Activity |
140.0 |
% |
10.1016/j.bmc.2008.10.015 |
| None |
NON-PROTEIN TARGET |
GI50 |
16.9 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| None |
NON-PROTEIN TARGET |
GI50 |
35.4 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| None |
NON-PROTEIN TARGET |
Potency |
2511.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
3548.1 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
3981.1 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
4466.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
7943.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
8912.5 |
nM |
None |
| None |
NON-PROTEIN TARGET |
TGI |
44.2 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| None |
NON-PROTEIN TARGET |
TGI |
71.7 |
ug.mL-1 |
10.1016/j.bmc.2014.11.019 |
| None |
Unchecked |
IC50 |
24000.0 |
nM |
10.1016/j.bmc.2009.12.071 |
| None |
Unchecked |
IC50 |
28000.0 |
nM |
10.1016/j.bmc.2009.12.071 |
| None |
Unchecked |
IC50 |
71000.0 |
nM |
10.1016/j.bmc.2009.12.071 |
| None |
Unchecked |
IC50 |
76000.0 |
nM |
10.1016/j.bmc.2009.12.071 |
| None |
Unchecked |
IC50 |
nan |
None |
10.1016/j.bmc.2009.12.071 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Potency |
39810.7 |
nM |
None |